{
  "id": "5880b583c872c95565000005",
  "type": "list",
  "question": "Which treatment methods were compared in the EXCEL Trial?",
  "ideal_answer": "EXCEL trial compared Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/21547994",
    "http://www.ncbi.nlm.nih.gov/pubmed/25983143",
    "http://www.ncbi.nlm.nih.gov/pubmed/26159652",
    "http://www.ncbi.nlm.nih.gov/pubmed/25583761",
    "http://www.ncbi.nlm.nih.gov/pubmed/21796086",
    "http://www.ncbi.nlm.nih.gov/pubmed/22941121",
    "http://www.ncbi.nlm.nih.gov/pubmed/22075415",
    "http://www.ncbi.nlm.nih.gov/pubmed/27639738",
    "http://www.ncbi.nlm.nih.gov/pubmed/22511269",
    "http://www.ncbi.nlm.nih.gov/pubmed/23995725"
  ],
  "snippets": [
    {
      "text": "Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25583761",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "AIMS: To prospectively validate the SYNTAX Score II and forecast the outcomes of the randomized Evaluation of the Xience Everolimus-Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) Trial.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25583761",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Based on 4-year mortality predictions in EXCEL, clinical characteristics shifted long-term mortality predictions either in favour of PCI (older age, male gender and COPD) or CABG (younger age, lower creatinine clearance, female gender, reduced left ventricular ejection fraction).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25583761",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Given that the completed randomized trials did not include contemporary DESs, the upcoming results of the ongoing trials evaluating the performance of new-generation DES compared with CABG (such as the EXCEL trial), may further help to clarify the current role and future recommendations of PCI for left main coronary artery disease. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26159652",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The ongoing EXCEL trial will help elucidate the role of ULMCA PCI in the treatment of left main disease compared with coronary artery bypass graft surgery.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23995725",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The ongoing Evaluation of XIENCE V Everolimus Eluting Stent System Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial is expected to provide a better answer on the optimal treatment strategy for LMCAD patients. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22941121",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The Evaluation of Xience Prime or Xience V versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial is a multicenter, ongoing trial conducted in patients with left main disease and SYNTAX score \u2264 32 to establish the presumptive advantage of percutaneous coronary intervention (PCI) versus bypass surgery in patients with less complex coronary artery disease than those enrolled in the Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) trial. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22075415",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The EXCEL trial will address the value of PCI in relation to CABG for the treatment of ULMCA stenosis in more than 2000 patients. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22511269",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVES: The aim of this study is to verify the study hypothesis of the EXCEL trial by comparing percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) in an EXCEL-like population of patients.BACKGROUND: The upcoming EXCEL trial will test the hypothesis that left main patients with SYNTAX score \u2264 32 experience similar rates of 3-year death, myocardial infarction (MI), or cerebrovascular accidents (CVA) following revascularization by PCI or CABG.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21547994",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CONCLUSIONS: In an EXCEL-like cohort of patients with left main disease, there seems to be a clinical equipoise between PCI and CABG in terms of death/MI/CVA. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21547994",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The aim of this study is to verify the study hypothesis of the EXCEL trial by comparing percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) in an EXCEL-like population of patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21547994",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "To prospectively validate the SYNTAX Score II and forecast the outcomes of the randomized Evaluation of the Xience Everolimus-Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) Trial.Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization is a prospective, randomized multicenter trial designed to establish the efficacy and safety of percutaneous coronary intervention (PCI) with the everolimus-eluting stent compared with coronary artery bypass graft (CABG) surgery in subjects with unprotected left-main coronary artery (ULMCA) disease and low-intermediate anatomical SYNTAX scores (&lt;33).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25583761",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVES: The aim of this study is to verify the study hypothesis of the EXCEL trial by comparing percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) in an EXCEL-like population of patients.BACKGROUND: The upcoming EXCEL trial will test the hypothesis that left main patients with SYNTAX score ?",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21547994",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The results of the ongoing EXCEL trial, which compares left main percutaneous coronary intervention with drug-eluting stents and CABG, will provide insight regarding the ideal revascularization strategy for these patients..",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21796086",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Given that the completed randomized trials did not include contemporary DESs, the upcoming results of the ongoing trials evaluating the performance of new-generation DES compared with CABG (such as the EXCEL trial), may further help to clarify the current role and future recommendations of PCI for left main coronary artery disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26159652",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The introduction of the newer-generation drug-eluting stents (DES) -with documented improvements in both safety and efficacy- has prompted the interventional community to design two new dedicated randomised trials comparing CABG and PCI: the NOBLE (Coronary Artery Bypass Grafting Vs Drug Eluting Stent Percutaneous Coronary Angioplasty in the Treatment of Unprotected Left Main Stenosis) and EXCEL (Evaluation of XIENCE Everolimus Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trials.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25983143",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The EXCEL trial will address the value of PCI in relation to CABG for the treatment of ULMCA stenosis in more than 2000 patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22511269",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The ongoing Evaluation of XIENCE V Everolimus Eluting Stent System Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial is expected to provide a better answer on the optimal treatment strategy for LMCAD patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22941121",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D017428",
    "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D002986",
    "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016430",
    "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D017326"
  ],
  "exact_answer": "Everolimus Eluting Stent, Coronary Artery Bypass Surgery"
}